Wesfarmers – Buy

Posted on | by Leon Hinde

Wesfarmers is under Algo Engine buy conditions and is a current holding in our model portfolio.

Wesfarmers now holds 19.3% of Australian Pharmaceutical Industries. The acquisition has less than two weeks left in confirmatory due diligence. The battle between Sigma and Wesfarmers for the API business and final offers will be worth watching.

Accumulate WES within the $50 – $56 price range.

.

CIMIC – Buy

Posted on | by Leon Hinde

CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.

CIMIC is a high-risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.

.

iShares Asia 50 ETF – Buy

Posted on | by Leon Hinde

iShares Asia 50 is under Algo Engine buy conditions and is a current holding in our iShares ETF model.

INVESTMENT OBJECTIVE: The fund aims to provide investors with the performance of the S&P Asia 50TM Index, before fees and expenses. The index is designed to measure the performance of the 50 leading companies listed in China, Hong Kong, Macau, Singapore, South Korea and Taiwan.

CIMIC – Buy

Posted on | by Leon Hinde

CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.

CIMIC is a high-risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.

.

September 2021: Algo Signal Performance Review.

Posted on | by Leon Hinde

The updated 5-year performance data for all Algo Engine buy and sell signals for the period ending 30 September.

Model Name: ASX S&P100 is 15.38% p/a.

Model Name: ASX ALL ETF is 14.85%.

Model Name: US S&P100 is 17.53% p/a.

June 2021 Data:

The updated 5-year performance data for all Algo Engine buy and sell signals for the period ending 30 June 2021

Model Name: ASX S&P100 is 14.87% p/a.

Model Name: ASX ALL ETF is 14.9%.

Model Name: US S&P100 is 19.29% p/a.

Disclaimer: This data illustrates the simulated 5 year historical time weighted rate of return of applying our algorithm based investment model over the ASX100 & US S&P100 listed securities. Past performance is no guarantee of future returns.

Wesfarmers – Buy

Posted on | by Leon Hinde

Wesfarmers is under Algo Engine buy conditions and is a current holding in our model portfolio.

Wesfarmers now holds 19.3% of Australian Pharmaceutical Industries. The acquisition has less than two weeks left in confirmatory due diligence. The battle between Sigma and Wesfarmers for the API business and final offers will be worth watching.

Accumulate WES within the $50 – $56 price range.

.